Last reviewed · How we verify
Evaluation of vaccines against flu
Evaluation of vaccines against flu is a vaccine Biologic drug developed by Assistance Publique - Hôpitaux de Paris. It is currently FDA-approved for Seasonal influenza prevention in adults and children, Influenza prevention in high-risk populations (elderly, immunocompromised, healthcare workers). Also known as: Evaluation of vaccines against flu in auto-imune diseases.
Flu vaccines stimulate the immune system to produce antibodies and cellular immunity against influenza virus strains, providing protection against infection and severe disease.
Flu vaccines stimulate the immune system to produce antibodies and cellular immunity against influenza virus strains, providing protection against infection and severe disease. Used for Seasonal influenza prevention in adults and children, Influenza prevention in high-risk populations (elderly, immunocompromised, healthcare workers).
At a glance
| Generic name | Evaluation of vaccines against flu |
|---|---|
| Also known as | Evaluation of vaccines against flu in auto-imune diseases |
| Sponsor | Assistance Publique - Hôpitaux de Paris |
| Drug class | vaccine |
| Modality | Biologic |
| Therapeutic area | Immunology |
| Phase | FDA-approved |
Mechanism of action
Flu vaccines contain inactivated or attenuated influenza virus antigens that trigger both humoral (antibody) and cell-mediated immune responses. This allows the body to recognize and rapidly neutralize circulating influenza viruses upon exposure, reducing infection rates and disease severity. Multiple vaccine formulations exist (trivalent, quadrivalent, high-dose, adjuvanted) targeting different age groups and risk populations.
Approved indications
- Seasonal influenza prevention in adults and children
- Influenza prevention in high-risk populations (elderly, immunocompromised, healthcare workers)
Common side effects
- Injection site soreness or erythema
- Myalgia
- Headache
- Low-grade fever
- Fatigue
Key clinical trials
- A Study to Learn About mRNA Vaccines Against Influenza in Adults (PHASE2)
- A Study To Learn About The Study Vaccine (Called Self-Amplifying Ribonucleic Acid (RNA)) For The Prevention of Influenza (PHASE1)
- A Study on the Safety, Reactogenicity and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older Adults (PHASE1)
- A Study to Find the Dose and Assess the Immune Response and Safety of a Vaccine Against Influenza in Healthy Younger and Older Adults (PHASE2)
- A Study to Learn How Safe, Tolerable and Capable of Producing an Immune Response is, a Modified RNA Vaccine Against Pandemic Influenza (PHASE1)
- A Study to Find and Confirm the Dose and Assess Safety, Reactogenicity and Immune Response of a Vaccine Against Pandemic H5N1 Influenza Virus in Healthy Younger and Older Adults (PHASE1, PHASE2)
- A Study to Learn About How the Flu and COVID-19 Vaccines Act in Healthy People (PHASE1, PHASE2)
- Study to Evaluate the Safety and the Immunogenicity of a Second Generation Structurally Designed mRNA Vaccine Candidate Against Pandemic Influenza H5 HA Strain in Healthy Adult Participants Aged 18 Years and Older (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Evaluation of vaccines against flu CI brief — competitive landscape report
- Evaluation of vaccines against flu updates RSS · CI watch RSS
- Assistance Publique - Hôpitaux de Paris portfolio CI
Frequently asked questions about Evaluation of vaccines against flu
What is Evaluation of vaccines against flu?
How does Evaluation of vaccines against flu work?
What is Evaluation of vaccines against flu used for?
Who makes Evaluation of vaccines against flu?
Is Evaluation of vaccines against flu also known as anything else?
What drug class is Evaluation of vaccines against flu in?
What development phase is Evaluation of vaccines against flu in?
What are the side effects of Evaluation of vaccines against flu?
Related
- Drug class: All vaccine drugs
- Manufacturer: Assistance Publique - Hôpitaux de Paris — full pipeline
- Therapeutic area: All drugs in Immunology
- Indication: Drugs for Seasonal influenza prevention in adults and children
- Indication: Drugs for Influenza prevention in high-risk populations (elderly, immunocompromised, healthcare workers)
- Also known as: Evaluation of vaccines against flu in auto-imune diseases
- Compare: Evaluation of vaccines against flu vs similar drugs
- Pricing: Evaluation of vaccines against flu cost, discount & access